Literature DB >> 25815300

Neuroprotective effects of porphyran derivatives against 6-hydroxydopamine-induced cytotoxicity is independent on mitochondria restoration.

Weiwei Wang1, Ning Song1, Fengjv Jia1, Junxia Xie1, Quanbin Zhang1, Hong Jiang1.   

Abstract

We previously reported that acetylated and phosphorylated derivatives of porphyran extracted from Porphyra haitanensis exhibit antioxidant activity in cell-free system. The aim of the present study was to investigate the neuroprotective effects of porphyran and its derivatives on 6-hydroxydopamine (6-OHDA)-induced cytotoxicity. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to measure cell viability. Changes in the mitochondrial transmembrane potential (ΔΨm) were measured by rhodamine123 using flow cytometry. The results showed that porphyran and its two derivatives, acetylated porphyran (AP) and phosphorylated porphyran (PP) (<1 mg/mL) alone did not have any toxic effects on MES23.5 cells. The cell viability decreased when cells were treated with 25 µmol/L 6-OHDA. Both AP and PP, rather than porphyran, significantly antagonized 25 µmol/L 6-OHDA-induced cytotoxicity. However, neither AP nor PP could antagonize 6-OHDA-induced mitochondrial transmembrane potential (ΔΨm) collapse. None of the three materials were effective on cell survival when cells were cotreated with 75 µmol/L 6-OHDA. These results suggest that two derivatives of porphyran, AP and PP, could antagonize the weak toxicity of 6-OHDA on MES23.5 dopaminergic cells, possessing minor neuroprotective effects independent of mitochondria restoration.

Entities:  

Keywords:  6-hydroxydopamine (6-OHDA); Porphyran; acetylated porphyran (AP); neuroprotective effects; phosphorylated porphyran (PP)

Year:  2015        PMID: 25815300      PMCID: PMC4356859          DOI: 10.3978/j.issn.2305-5839.2015.01.33

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  20 in total

Review 1.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

Review 2.  Parkinson's disease: genetics and pathogenesis.

Authors:  Joshua M Shulman; Philip L De Jager; Mel B Feany
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 3.  Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease.

Authors:  David Sulzer
Journal:  Trends Neurosci       Date:  2007-04-05       Impact factor: 13.837

4.  Preparation of the different derivatives of the low-molecular-weight porphyran from Porphyra haitanensis and their antioxidant activities in vitro.

Authors:  Zhongshan Zhang; Quanbin Zhang; Jing Wang; Hong Zhang; Xizhen Niu; Pengcheng Li
Journal:  Int J Biol Macromol       Date:  2009-04-02       Impact factor: 6.953

5.  Potential antioxidant capacity of sulfated polysaccharides from the edible marine brown seaweed Fucus vesiculosus.

Authors:  Pilar Rupérez; Oussama Ahrazem; J Antonio Leal
Journal:  J Agric Food Chem       Date:  2002-02-13       Impact factor: 5.279

Review 6.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

Authors:  D Blum; S Torch; N Lambeng; M Nissou; A L Benabid; R Sadoul; J M Verna
Journal:  Prog Neurobiol       Date:  2001-10       Impact factor: 11.685

7.  An in vitro study of the structure-activity relationships of sulfated polysaccharide from brown algae to its antioxidant effect.

Authors:  J F Hu; M Y Gen; J T Zhang; H D Jiang
Journal:  J Asian Nat Prod Res       Date:  2001       Impact factor: 1.569

Review 8.  Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Authors:  Naveen Kumar Singhal; Garima Srivastava; Sonal Agrawal; Swatantra Kumar Jain; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2011-12-24       Impact factor: 5.590

Review 9.  Advances in the genetics of Parkinson disease.

Authors:  Joanne Trinh; Matt Farrer
Journal:  Nat Rev Neurol       Date:  2013-07-16       Impact factor: 42.937

10.  Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells.

Authors:  Jun Wang; Xi-Xun Du; Hong Jiang; Jun-Xia Xie
Journal:  Biochem Pharmacol       Date:  2009-04-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.